0001104659-21-064573.txt : 20210511
0001104659-21-064573.hdr.sgml : 20210511
20210511164047
ACCESSION NUMBER: 0001104659-21-064573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210507
FILED AS OF DATE: 20210511
DATE AS OF CHANGE: 20210511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LLOYD RONALD K.
CENTRAL INDEX KEY: 0001644078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39577
FILM NUMBER: 21911920
MAIL ADDRESS:
STREET 1: C/O MALLINCKRODT PHARMACEUTICALS
STREET 2: 675 MCDONNELL BLVD.
CITY: HAZELWOOD
STATE: MO
ZIP: 63042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001708527
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474790334
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
BUSINESS PHONE: 240-247-1143
MAIL ADDRESS:
STREET 1: 12510 PROSPERITY DRIVE
STREET 2: SUITE 370
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
4
1
tm2115948-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-05-07
0
0001708527
AZIYO BIOLOGICS, INC.
AZYO
0001644078
LLOYD RONALD K.
C/O AZIYO BIOLOGICS, INC., 12510
PROSPERITY DRIVE, SUITE 370
SILVER SPRING
MD
20904
1
1
0
0
PRESIDENT AND CEO
Class A Common Stock
2021-05-07
4
P
0
7198
11.65
A
21784
D
Class A Common Stock
2021-05-07
4
P
0
1367
12.28
A
23151
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.20 to $12.18. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Ronald Lloyd
2021-05-11